CorMedix Inc.(CRMD)Earnings Date, History & Expected Move
Next report date, beat rate and options-implied move
CRMD is scheduled to report on Nov 11, 2026, usually before the market opens. Analysts expect EPS of -$0.11.
EPS: Actual vs Estimate
Reported EPS against the consensus estimate, last 12 quarters.
Green beat or met, red missed, amber sources differ.
Stock Reaction After Earnings
Close-to-close move in the first session that reflected each report.
Dashed lines mark the average actual move (±14.8%).
Did the stock rise after good news?
The next-day move after each of its last 9 EPS beats and 1 misses.
In plain words: it beat expectations 9 times, but the stock still fell 4 of those 9 times.
- Aug '26Beat▲ +14.6%
- May '26Beat▲ +5.7%
- Mar '26Missed▼ -11.5%
- Nov '25Beat▲ +2.1%
- Aug '25Beat▼ -9.5%
- May '25Beat▲ +23.6%
- Mar '25Beat▼ -31.8%
- Oct '24Beat▼ -22.5%
- May '24Beat▼ -5.3%
- Nov '23Beat▲ +6.4%
Clear beats and misses with a known reaction only. What counts as a beat
Why did CRMD fall after beating earnings?
4 of CRMD's last 10 reactions went against the EPS result. What stands out in each:
CRMD beat EPS estimates in 9 quarters, and the stock still closed lower the next day 4 times. In 4 of the 4 where we have price data, the stock had already run up before the report.
- Aug 7, 2025EPS beat +47.4%stock -9.5% next day
- It had risen 5.3% in the 20 trading sessions before the report, so good news may already have been priced in.
- Mar 25, 2025EPS beat +57.1%stock -31.8% next day
- It had risen 6.6% in the 20 trading sessions before the report, so good news may already have been priced in.
- It opened 19.3% lower as soon as trading resumed.
- Oct 30, 2024EPS beat +50.0%stock -22.5% next day
- It had risen 60.1% in the 20 trading sessions before the report, so good news may already have been priced in.
- It opened 12.6% lower as soon as trading resumed.
- May 9, 2024EPS beat +10.7%stock -5.3% next day
- It had risen 8.1% in the 20 trading sessions before the report, so good news may already have been priced in.
- It opened 2.5% higher, but sellers took over and it closed -5.3%.
Patterns in estimates and prices, not confirmed causes: how we read them.
Was CRMD's earnings move already priced in?
CRMD's move in the month before each of its last 11 reports, against what it did after.
How the run-up is measured (a move of 5% or more counts as large).
Before vs after each report
Grey: the month before each of the last 11 reports. Green or red: the day after.
Past reports only. How the run-up is measured
Does CRMD hold its opening gap after earnings?
CRMD's opening move after each report and where it closed that day.
In 10 reports CRMD opened at least 1% away from the previous close. It gave back half or more of that gap by the close 4 of 10 times (40%), and fully reversed 1 time. Gaps up faded 4 of 7; gaps down recovered 0 of 3.
- Aug 13, 2026HeldOpened +18.2%, closed +14.6%
- May 14, 2026FadedOpened +14.0%, closed +5.7%
- Mar 5, 2026HeldOpened -10.8%, closed -11.5%
- Nov 12, 2025FadedOpened +4.9%, closed +2.1%
- May 6, 2025HeldOpened +6.2%, closed +23.6%
- Mar 25, 2025HeldOpened -19.3%, closed -31.8%
- Oct 30, 2024HeldOpened -12.6%, closed -22.5%
- Aug 14, 2024HeldOpened +9.8%, closed +30.2%
What the history says
- It fell after 4 of its 9 EPS beats (44%): beating estimates has not been enough on its own.
CRMD earnings history
Last 12 reported quarters with the stock's reaction.
Swipe sideways to see every column →
| Report date | Time | EPS est. | EPS actual | Surprise | 1-day move | 3-day move |
|---|---|---|---|---|---|---|
| Aug 13, 2026 | Before open | $0.24 | $0.29 | +20.8% | +14.65% | +8.03% |
| May 14, 2026 | Before open | $0.33 | $0.35 | +6.1% | +5.73% | +5.47% |
| Mar 5, 2026 | Before open | $0.81 | $0.16 | -80.2% | -11.52% | -7.87% |
| Nov 12, 2025 | Before open | $0.63 | $1.41 | +123.8% | +2.06% | +0.45% |
| Aug 7, 2025 | Before open | $0.19 | $0.28 | +47.4% | -9.54% | -15.73% |
| May 6, 2025 | Before open | $0.25 | $0.30 | +20.0% | +23.59% | +33.22% |
| Mar 25, 2025 | Before open | $0.14 | $0.22 | +57.1% | -31.85% | -37.70% |
| Oct 30, 2024 | Before open | -$0.10 | -$0.05 | +50.0% | -22.51% | -22.98% |
| Aug 14, 2024 | Before open | -$0.25 | -$0.25 | 0.0% | +30.16% | +27.25% |
| May 9, 2024 | Before open | -$0.28 | -$0.25 | +10.7% | -5.25% | -7.18% |
| Mar 12, 2024 | Before open | -$0.20 | -$0.26 | -30.0% | — | — |
| Nov 14, 2023 | After close | -$0.21 | -$0.17 | +19.0% | +6.39% | +28.12% |
Consensus for the next report: EPS -$0.11, revenue $54.29M.
CRMD Earnings FAQ
Answers computed from CorMedix Inc.'s reported history
CRMD is scheduled to report on Nov 11, 2026, usually before the market opens. Analysts expect EPS of -$0.11.
Over the last 12 quarters with a usable EPS surprise, CRMD beat the consensus estimate 9 times (75%), missed 2 and landed in line 1. It has beaten estimates in each of the last 2 counted quarters.
Across its last 11 quarters with a measured reaction, CRMD moved an average of ±14.8% in the first session after reporting. It closed higher 55% of the time; the largest gain was 30.2% and the largest drop -31.9%.
CRMD fell in the first session after 4 of its last 9 EPS beats (44%). A beat that was already priced in, or weaker guidance, can send a stock lower. In 4 of the 4 of those falls where price data is available, the stock had already risen before the report.
Across its last 11 quarters with price data, CRMD moved an average of +7.5% in the 20 trading sessions before reporting and was higher in 64% of them. After a run-up of 3% or more (7 quarters), it fell the next day 57% of the time, averaging -5.4%. After a drop of 3% or more (4 quarters), it rose the next day 75% of the time, averaging +9.9%. This describes past reports; it is not a forecast.
In 10 reports CRMD opened at least 1% away from the previous close. It gave back half or more of that gap by the close 4 of 10 times (40%), and fully reversed once. A fade means the opening move was partly undone during the first session.
How we calculate these numbers · CRMD: 12 reported quarters, latest Aug 13, 2026. Information only, not investment advice.
Looking for more on CRMD?
Price charts, forecast, fundamentals and risk pages for CRMD are not on Tickzen yet. You can run a full stock analysis now.
Run the CRMD Stock AnalyzerLatest TickZen Insights
HSBC Q3 2026 Earnings Preview: Is the $46bn NII Guide Too Low?By Vishal Jadaun
Coca-Cola (KO) Q3 2026 Earnings Preview: Can Growth Justify Its Valuation?By Vishal Jadaun
Welltower Q3 2026 Earnings Preview: Can 20% Senior Housing Growth Last?By Vishal Jadaun